Collingwood livewire Jamie Elliott set for stint on the sidelines
Collingwood livewire Jamie Elliott is facing several weeks on the sidelines after being diagnosed with a vascular issue.
Mind Over Money: 50,000 steps per week, yoga and meditation keep this CEO mentally & physically fit
Abhijit Bhave, MD & CEO of Equirus Wealth, exemplifies the fusion of leadership and holistic health practices, emphasizing ...
First Patient Begins Newly Approved Sickle Cell Gene Therapy
A 12-year-old boy in the Washington, D.C., area faces months of procedures to remedy his disease. “I want to be cured,” he ...
Boehringer reports positive findings from diabetic macular ischemia trial
BI 764524 demonstrated to be well tolerated following intravitreal administration of single and multiple doses.
Microsoft Start Health on MSN2d
Ask A Doctor: What Are The Complications Of Sle?
Expert opinion from Ipsa Arora MD (Internal Medicine) · 5 years of experience · USA Complications related to SLE include: ...
First patient, age 12, begins newly approved sickle cell gene therapy
A 12-year-old boy in the Washington, D.C., area faces months of procedures to remedy his disease. “I want to be cured,” he ...
Medscape13d
This Tech Will Change Your Practice Sooner Than You Think
These five advanced technologies are already a reality for many doctors and could hit your office in the next few years.
Fox 61 anchor Tim Lammers plans on returning to station Monday, weeks after hip surgery
Fox 61 morning news anchor Tim Lammers plans on returning to the station May 6, several weeks after his hip replacement ...
Boehringer Ingelheim shares positive results from the first study worldwide in diabetic macular ischemia
Boehringer Ingelheim today presented positive data from the HORNBILL Phase I/IIa study of BI 764524, the first ever study exploring a potential ...